Balyasny Asset Management LLC Arrowhead Pharmaceuticals, Inc. Call Options Transaction History

Balyasny Asset Management LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$29.63 - $48.31 $1.48 Million - $2.42 Million	50,000 New	50,000 $1.65 Million
Q3 2021 Nov 15, 2021	SELL	$58.38 - $84.96 $5.83 Million - $8.48 Million	-99,800 Reduced 76.77%	30,200 $1.89 Million
Q2 2021 Aug 16, 2021	BUY	$62.15 - $90.32 $6.22 Million - $9.03 Million	100,000 Added 333.33%	130,000 $10.8 Million
Q3 2020 Nov 16, 2020	BUY	$33.21 - $51.27 $996,300 - $1.54 Million	30,000 New	30,000 $1.29 Million

294

90.8M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.07B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.